Medpace Medical Device
3787 95th Avenue
Minneapolis, Minnesota 55014
MediTech Strategic Consultants B.V.
NL – 6291 EN Vaals
Download a summary document of Medpace's medical device capabilities. (Medical Device Fact Sheet - pdf format)
Download a summary document on Medpace's extensive experience conducting trials for cardiovascular devices. (Cardiovascular Device Fact Sheet - pdf format)
Medpace is ready to help you with your next clinical trial project. Find out more about how we can help.
6th Annual Commercialize It Program
Carla Kikken-Jussen of MediTech, will be attending the next Commercialize It meeting on May 1, hosted by Rice University’s Institute of Biosciences and Bioengineering (IBB).
In collaboration with the Houston Technology Center (HTC), the Rice Alliance, the Rice Office of Technology Transfer (OTT), and the Houston Area Translational Research Consortium (HATRC), IBB will continue the “Commercialize It” Program in 2013 to help researchers commercialize their ideas. For this program, commercializing specialists discuss and evaluate commercializing options for devices and processes that are emerging from Rice affiliated faculty, staff or senior students.
The combined power of two Medical Device leaders
Medpace Medical Device
Meditech, Strategic Consultants, B.V.
Medpace, a global, full-service, contract research organization (CRO) recently acquired Meditech Strategic Consultants B.V. based in The Netherlands. MediTech joins Medpace Medical Device (MMD) to support medical device clinical studies on a global scale. This merger of two industry leaders in medical device research enables sponsors to conduct device studies with global infrastructure, capitalizing on therapeutic and regulatory expertise in study design and execution.
Whether you are an early stage business whose future depends on the success of one breakthrough technology, or a well-established device manufacturer, we can help. Medpace Medical Device
and MediTech have experience with premarket, post-approval, and post-market device trial management, including regulatory development, planning and submission support. We support human trials in all phases, from single-center feasibility trials to large multi-center, randomized controlled trials, with a full service offering.
Outsourcing your clinical trial requires global CRO partners you can trust. We pride ourselves on the relationships we build with our research sites and understand the need for local regulatory knowledge, and local presence at the sites. Working in over 40 countries, Medpace and MediTech have the breadth and depth to support your medical device trial in any geography.
When it comes to clinical research, the right experience matters. Successful device trials require a specialized knowledge and a CRO with practical, real-world device trials experience. Whether your trial is a single-center pilot trial or a global multi-center trial, we have the experience and resources to deliver results. With expertise in IDE / pre-market, post-approval, and post-market/outcomes trials, Medpace Medical Device offers best-in-class clinical trial management solutions to medical device companies, and has built a reputation for delivering results with a strong sense of accountability to our customers.
- Over 1000 site relationships in the US, Europe, and emerging markets
- Over 63,000 patients enrolled in 240 studies
- Over 3000 sites covered
Carla Kikken and Ryan Wilson recently presented how MediTech and Medpace Medical Device lend global advantage at MedTech, May 2013.
Want to learn more? Browse our capabilities, or contact the location nearest you.